Intimation of investor meeting.
FERMENTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fermenta Biotech has informed the stock exchange that its officials will hold a one-to-one investor meeting on February 24, 2026, in Mumbai on a physical basis. The company has clarified that no unpublished price-sensitive information (UPSI) will be discussed during this interaction. The meeting will likely cover the company's unaudited financial results for the quarter and nine months ended December 31, 2025, along with the relevant investor presentation, both of which were already uploaded on the company's and BSE's websites on February 9, 2026. The disclosure is filed under SEBI's Listing Obligations and Disclosure Requirements (Regulation 30).
This is a routine regulatory disclosure and is generally neutral for shareholders, as only already-public information will be discussed. Investors should monitor for any subsequent insights shared from the meeting, but no new financial or strategic disclosure is expected at this point.